nodes	percent_of_prediction	percent_of_DWPC	metapath
Bortezomib—Lacosamide—Phentermine—obesity	0.114	0.269	CrCrCtD
Bortezomib—Nateglinide—Methamphetamine—obesity	0.107	0.252	CrCrCtD
Bortezomib—Aspartame—Methamphetamine—obesity	0.102	0.239	CrCrCtD
Bortezomib—Lacosamide—Methamphetamine—obesity	0.102	0.239	CrCrCtD
Bortezomib—CYP2C8—Bupropion—obesity	0.0211	0.0788	CbGbCtD
Bortezomib—CYP1A2—Phentermine—obesity	0.0192	0.0717	CbGbCtD
Bortezomib—CYP1A2—Phenylpropanolamine—obesity	0.0183	0.0684	CbGbCtD
Bortezomib—CYP2C9—Phentermine—obesity	0.0173	0.0646	CbGbCtD
Bortezomib—CYP1A2—Bupropion—obesity	0.0163	0.061	CbGbCtD
Bortezomib—CYP2D6—Phentermine—obesity	0.0158	0.0591	CbGbCtD
Bortezomib—CYP2C8—Cimetidine—obesity	0.0155	0.0578	CbGbCtD
Bortezomib—CYP2C9—Bupropion—obesity	0.0147	0.0549	CbGbCtD
Bortezomib—CYP2D6—Bupropion—obesity	0.0134	0.0502	CbGbCtD
Bortezomib—CYP3A4—Sibutramine—obesity	0.0133	0.0496	CbGbCtD
Bortezomib—CYP2C19—Cimetidine—obesity	0.013	0.0485	CbGbCtD
Bortezomib—CYP2D6—Methamphetamine—obesity	0.0126	0.0472	CbGbCtD
Bortezomib—CYP1A2—Cimetidine—obesity	0.012	0.0448	CbGbCtD
Bortezomib—CYP2C9—Cimetidine—obesity	0.0108	0.0403	CbGbCtD
Bortezomib—CYP3A4—Benzphetamine—obesity	0.0101	0.0376	CbGbCtD
Bortezomib—CYP2D6—Cimetidine—obesity	0.00987	0.0369	CbGbCtD
Bortezomib—CYP3A4—Bupropion—obesity	0.00855	0.0319	CbGbCtD
Bortezomib—CYP2C19—Topiramate—obesity	0.0085	0.0318	CbGbCtD
Bortezomib—CYP3A4—Orlistat—obesity	0.00697	0.026	CbGbCtD
Bortezomib—CYP3A4—Cimetidine—obesity	0.00627	0.0234	CbGbCtD
Bortezomib—CYP3A4—Topiramate—obesity	0.00411	0.0153	CbGbCtD
Bortezomib—CTSG—respiratory system—obesity	0.00166	0.0277	CbGeAlD
Bortezomib—PSMA1—respiratory system—obesity	0.0016	0.0266	CbGeAlD
Bortezomib—PSMD1—islet of Langerhans—obesity	0.00142	0.0237	CbGeAlD
Bortezomib—Lacosamide—CA3—obesity	0.00135	0.498	CrCbGaD
Bortezomib—CTSG—cardiovascular system—obesity	0.00127	0.0212	CbGeAlD
Bortezomib—PSMD2—islet of Langerhans—obesity	0.00126	0.021	CbGeAlD
Bortezomib—PSMB8—islet of Langerhans—obesity	0.00125	0.0208	CbGeAlD
Bortezomib—PSMA1—cardiovascular system—obesity	0.00122	0.0204	CbGeAlD
Bortezomib—PSMD2—respiratory system—obesity	0.00119	0.0198	CbGeAlD
Bortezomib—PSMD1—adrenal cortex—obesity	0.00112	0.0188	CbGeAlD
Bortezomib—CTSG—adipose tissue—obesity	0.00112	0.0187	CbGeAlD
Bortezomib—PSMB5—islet of Langerhans—obesity	0.0011	0.0184	CbGeAlD
Bortezomib—PSMA1—adipose tissue—obesity	0.00108	0.018	CbGeAlD
Bortezomib—Aspartame—TRPV1—obesity	0.00106	0.392	CrCbGaD
Bortezomib—PSMA1—digestive system—obesity	0.00102	0.0169	CbGeAlD
Bortezomib—CTSG—adrenal gland—obesity	0.00101	0.0168	CbGeAlD
Bortezomib—PSMD2—adrenal cortex—obesity	0.000997	0.0166	CbGeAlD
Bortezomib—PSMB8—adrenal cortex—obesity	0.00099	0.0165	CbGeAlD
Bortezomib—PSMA1—adrenal gland—obesity	0.000967	0.0161	CbGeAlD
Bortezomib—PSMB1—islet of Langerhans—obesity	0.000965	0.0161	CbGeAlD
Bortezomib—PSMB2—islet of Langerhans—obesity	0.000941	0.0157	CbGeAlD
Bortezomib—PSMB1—respiratory system—obesity	0.000911	0.0152	CbGeAlD
Bortezomib—PSMD2—cardiovascular system—obesity	0.000909	0.0152	CbGeAlD
Bortezomib—PSMD1—pituitary gland—obesity	0.000909	0.0152	CbGeAlD
Bortezomib—PSMD1—adipose tissue—obesity	0.000905	0.0151	CbGeAlD
Bortezomib—PSMB2—respiratory system—obesity	0.000889	0.0148	CbGeAlD
Bortezomib—PSMB5—adrenal cortex—obesity	0.000875	0.0146	CbGeAlD
Bortezomib—CTSG—endocrine gland—obesity	0.000874	0.0146	CbGeAlD
Bortezomib—PSMA1—endocrine gland—obesity	0.000839	0.014	CbGeAlD
Bortezomib—PSMD1—adrenal gland—obesity	0.000812	0.0135	CbGeAlD
Bortezomib—PSMD2—pituitary gland—obesity	0.000805	0.0134	CbGeAlD
Bortezomib—PSMD2—adipose tissue—obesity	0.000802	0.0134	CbGeAlD
Bortezomib—PSMB8—pituitary gland—obesity	0.0008	0.0133	CbGeAlD
Bortezomib—PSMB8—adipose tissue—obesity	0.000797	0.0133	CbGeAlD
Bortezomib—SLC31A1—respiratory system—obesity	0.00077	0.0128	CbGeAlD
Bortezomib—PSMB1—adrenal cortex—obesity	0.000765	0.0128	CbGeAlD
Bortezomib—PSMA1—liver—obesity	0.000756	0.0126	CbGeAlD
Bortezomib—PSMD2—digestive system—obesity	0.000755	0.0126	CbGeAlD
Bortezomib—PSMB2—adrenal cortex—obesity	0.000746	0.0124	CbGeAlD
Bortezomib—PSMD2—adrenal gland—obesity	0.000719	0.012	CbGeAlD
Bortezomib—PSMB8—adrenal gland—obesity	0.000715	0.0119	CbGeAlD
Bortezomib—PSMB5—pituitary gland—obesity	0.000707	0.0118	CbGeAlD
Bortezomib—PSMB5—adipose tissue—obesity	0.000704	0.0117	CbGeAlD
Bortezomib—PSMB1—cardiovascular system—obesity	0.000698	0.0116	CbGeAlD
Bortezomib—PSMB2—cardiovascular system—obesity	0.000681	0.0114	CbGeAlD
Bortezomib—SLC31A1—adrenal cortex—obesity	0.000646	0.0108	CbGeAlD
Bortezomib—PSMD1—liver—obesity	0.000635	0.0106	CbGeAlD
Bortezomib—PSMB5—adrenal gland—obesity	0.000632	0.0105	CbGeAlD
Bortezomib—PSMD2—endocrine gland—obesity	0.000624	0.0104	CbGeAlD
Bortezomib—PSMB1—pituitary gland—obesity	0.000618	0.0103	CbGeAlD
Bortezomib—PSMB1—adipose tissue—obesity	0.000615	0.0103	CbGeAlD
Bortezomib—PSMB2—pituitary gland—obesity	0.000603	0.0101	CbGeAlD
Bortezomib—PSMB2—adipose tissue—obesity	0.0006	0.01	CbGeAlD
Bortezomib—PSMB1—digestive system—obesity	0.000579	0.00966	CbGeAlD
Bortezomib—PSMB2—digestive system—obesity	0.000565	0.00943	CbGeAlD
Bortezomib—PSMD2—liver—obesity	0.000562	0.00938	CbGeAlD
Bortezomib—PSMB8—liver—obesity	0.000559	0.00932	CbGeAlD
Bortezomib—PSMB1—adrenal gland—obesity	0.000552	0.00921	CbGeAlD
Bortezomib—PSMB2—adrenal gland—obesity	0.000539	0.00898	CbGeAlD
Bortezomib—SLC31A1—pituitary gland—obesity	0.000522	0.00871	CbGeAlD
Bortezomib—SLC31A1—adipose tissue—obesity	0.00052	0.00867	CbGeAlD
Bortezomib—PSMB5—liver—obesity	0.000494	0.00824	CbGeAlD
Bortezomib—SLC31A1—digestive system—obesity	0.000489	0.00816	CbGeAlD
Bortezomib—PSMB1—endocrine gland—obesity	0.000479	0.00798	CbGeAlD
Bortezomib—PSMB2—endocrine gland—obesity	0.000467	0.00779	CbGeAlD
Bortezomib—SLC31A1—adrenal gland—obesity	0.000466	0.00778	CbGeAlD
Bortezomib—PSMB1—liver—obesity	0.000432	0.0072	CbGeAlD
Bortezomib—PSMB2—liver—obesity	0.000421	0.00702	CbGeAlD
Bortezomib—SLC31A1—endocrine gland—obesity	0.000404	0.00675	CbGeAlD
Bortezomib—SLC31A1—liver—obesity	0.000365	0.00608	CbGeAlD
Bortezomib—CYP2D6—hindbrain—obesity	0.000309	0.00516	CbGeAlD
Bortezomib—CYP1A2—respiratory system—obesity	0.000265	0.00442	CbGeAlD
Bortezomib—CYP1A1—respiratory system—obesity	0.000261	0.00436	CbGeAlD
Bortezomib—PTGS1—respiratory system—obesity	0.00023	0.00383	CbGeAlD
Bortezomib—Nateglinide—PPARG—obesity	0.000216	0.08	CrCbGaD
Bortezomib—CYP2C19—digestive system—obesity	0.000206	0.00344	CbGeAlD
Bortezomib—CYP2C9—cardiovascular system—obesity	0.000193	0.00321	CbGeAlD
Bortezomib—CYP2C8—pituitary gland—obesity	0.000192	0.0032	CbGeAlD
Bortezomib—CYP1A1—adipose tissue—obesity	0.000177	0.00295	CbGeAlD
Bortezomib—PTGS1—cardiovascular system—obesity	0.000176	0.00293	CbGeAlD
Bortezomib—CYP2C19—endocrine gland—obesity	0.000171	0.00284	CbGeAlD
Bortezomib—CYP1A2—digestive system—obesity	0.000169	0.00281	CbGeAlD
Bortezomib—CYP1A1—digestive system—obesity	0.000166	0.00277	CbGeAlD
Bortezomib—CYP2C9—digestive system—obesity	0.00016	0.00267	CbGeAlD
Bortezomib—PTGS1—pituitary gland—obesity	0.000156	0.0026	CbGeAlD
Bortezomib—PTGS1—adipose tissue—obesity	0.000155	0.00259	CbGeAlD
Bortezomib—CYP2C19—liver—obesity	0.000154	0.00256	CbGeAlD
Bortezomib—CYP2C8—endocrine gland—obesity	0.000149	0.00248	CbGeAlD
Bortezomib—PTGS1—digestive system—obesity	0.000146	0.00244	CbGeAlD
Bortezomib—CYP1A2—endocrine gland—obesity	0.000139	0.00232	CbGeAlD
Bortezomib—PTGS1—adrenal gland—obesity	0.000139	0.00232	CbGeAlD
Bortezomib—CYP1A1—endocrine gland—obesity	0.000137	0.00229	CbGeAlD
Bortezomib—CYP2C8—liver—obesity	0.000134	0.00224	CbGeAlD
Bortezomib—CYP2C9—endocrine gland—obesity	0.000132	0.0022	CbGeAlD
Bortezomib—CYP1A2—liver—obesity	0.000126	0.00209	CbGeAlD
Bortezomib—CYP1A1—liver—obesity	0.000124	0.00207	CbGeAlD
Bortezomib—CYP3A4—digestive system—obesity	0.000122	0.00203	CbGeAlD
Bortezomib—PTGS1—endocrine gland—obesity	0.000121	0.00201	CbGeAlD
Bortezomib—CYP2D6—digestive system—obesity	0.00012	0.002	CbGeAlD
Bortezomib—CYP2C9—liver—obesity	0.000119	0.00199	CbGeAlD
Bortezomib—CYP3A4—endocrine gland—obesity	0.000101	0.00168	CbGeAlD
Bortezomib—CYP2D6—endocrine gland—obesity	9.92e-05	0.00165	CbGeAlD
Bortezomib—CYP3A4—liver—obesity	9.09e-05	0.00152	CbGeAlD
Bortezomib—CYP2D6—liver—obesity	8.94e-05	0.00149	CbGeAlD
Bortezomib—Nateglinide—ALB—obesity	8.14e-05	0.0301	CrCbGaD
Bortezomib—Flatulence—Bupropion—obesity	5.93e-05	0.000439	CcSEcCtD
Bortezomib—Dehydration—Topiramate—obesity	5.92e-05	0.000438	CcSEcCtD
Bortezomib—Dysgeusia—Bupropion—obesity	5.89e-05	0.000436	CcSEcCtD
Bortezomib—Myalgia—Sibutramine—obesity	5.87e-05	0.000435	CcSEcCtD
Bortezomib—Chest pain—Sibutramine—obesity	5.87e-05	0.000435	CcSEcCtD
Bortezomib—Arthralgia—Sibutramine—obesity	5.87e-05	0.000435	CcSEcCtD
Bortezomib—Anxiety—Sibutramine—obesity	5.85e-05	0.000434	CcSEcCtD
Bortezomib—Anaphylactic shock—Orlistat—obesity	5.82e-05	0.000431	CcSEcCtD
Bortezomib—Oedema—Orlistat—obesity	5.82e-05	0.000431	CcSEcCtD
Bortezomib—Back pain—Bupropion—obesity	5.82e-05	0.000431	CcSEcCtD
Bortezomib—Abdominal pain upper—Topiramate—obesity	5.81e-05	0.00043	CcSEcCtD
Bortezomib—Orthostatic hypotension—Topiramate—obesity	5.81e-05	0.00043	CcSEcCtD
Bortezomib—Discomfort—Sibutramine—obesity	5.8e-05	0.00043	CcSEcCtD
Bortezomib—Hypokalaemia—Topiramate—obesity	5.79e-05	0.000429	CcSEcCtD
Bortezomib—Muscle spasms—Bupropion—obesity	5.78e-05	0.000428	CcSEcCtD
Bortezomib—Infection—Orlistat—obesity	5.78e-05	0.000428	CcSEcCtD
Bortezomib—Breast disorder—Topiramate—obesity	5.75e-05	0.000426	CcSEcCtD
Bortezomib—Toxic epidermal necrolysis—Topiramate—obesity	5.73e-05	0.000424	CcSEcCtD
Bortezomib—Nervous system disorder—Orlistat—obesity	5.7e-05	0.000423	CcSEcCtD
Bortezomib—Nasopharyngitis—Topiramate—obesity	5.69e-05	0.000421	CcSEcCtD
Bortezomib—Confusional state—Sibutramine—obesity	5.68e-05	0.000421	CcSEcCtD
Bortezomib—Vision blurred—Bupropion—obesity	5.67e-05	0.00042	CcSEcCtD
Bortezomib—Skin disorder—Orlistat—obesity	5.65e-05	0.000419	CcSEcCtD
Bortezomib—Tremor—Bupropion—obesity	5.63e-05	0.000417	CcSEcCtD
Bortezomib—Gastritis—Topiramate—obesity	5.63e-05	0.000417	CcSEcCtD
Bortezomib—Anaphylactic shock—Sibutramine—obesity	5.63e-05	0.000417	CcSEcCtD
Bortezomib—Oedema—Sibutramine—obesity	5.63e-05	0.000417	CcSEcCtD
Bortezomib—Hyperhidrosis—Orlistat—obesity	5.62e-05	0.000417	CcSEcCtD
Bortezomib—Muscular weakness—Topiramate—obesity	5.61e-05	0.000416	CcSEcCtD
Bortezomib—Infection—Sibutramine—obesity	5.59e-05	0.000414	CcSEcCtD
Bortezomib—Ill-defined disorder—Bupropion—obesity	5.58e-05	0.000413	CcSEcCtD
Bortezomib—Anaemia—Bupropion—obesity	5.56e-05	0.000412	CcSEcCtD
Bortezomib—Shock—Sibutramine—obesity	5.54e-05	0.00041	CcSEcCtD
Bortezomib—Abdominal distension—Topiramate—obesity	5.54e-05	0.00041	CcSEcCtD
Bortezomib—Agitation—Bupropion—obesity	5.53e-05	0.000409	CcSEcCtD
Bortezomib—Thrombocytopenia—Sibutramine—obesity	5.51e-05	0.000408	CcSEcCtD
Bortezomib—Dysphagia—Topiramate—obesity	5.5e-05	0.000407	CcSEcCtD
Bortezomib—Angioedema—Bupropion—obesity	5.49e-05	0.000407	CcSEcCtD
Bortezomib—Tachycardia—Sibutramine—obesity	5.49e-05	0.000407	CcSEcCtD
Bortezomib—Skin disorder—Sibutramine—obesity	5.47e-05	0.000405	CcSEcCtD
Bortezomib—Hyperhidrosis—Sibutramine—obesity	5.44e-05	0.000403	CcSEcCtD
Bortezomib—Malaise—Bupropion—obesity	5.42e-05	0.000402	CcSEcCtD
Bortezomib—Vertigo—Bupropion—obesity	5.4e-05	0.0004	CcSEcCtD
Bortezomib—Syncope—Bupropion—obesity	5.39e-05	0.0004	CcSEcCtD
Bortezomib—Pancreatitis—Topiramate—obesity	5.39e-05	0.000399	CcSEcCtD
Bortezomib—Leukopenia—Bupropion—obesity	5.38e-05	0.000399	CcSEcCtD
Bortezomib—Anorexia—Sibutramine—obesity	5.37e-05	0.000398	CcSEcCtD
Bortezomib—Angina pectoris—Topiramate—obesity	5.36e-05	0.000397	CcSEcCtD
Bortezomib—Palpitations—Bupropion—obesity	5.31e-05	0.000394	CcSEcCtD
Bortezomib—Musculoskeletal discomfort—Orlistat—obesity	5.3e-05	0.000393	CcSEcCtD
Bortezomib—Bronchitis—Topiramate—obesity	5.29e-05	0.000392	CcSEcCtD
Bortezomib—Loss of consciousness—Bupropion—obesity	5.29e-05	0.000392	CcSEcCtD
Bortezomib—Abdominal discomfort—Topiramate—obesity	5.27e-05	0.000391	CcSEcCtD
Bortezomib—Insomnia—Orlistat—obesity	5.26e-05	0.00039	CcSEcCtD
Bortezomib—Hypotension—Sibutramine—obesity	5.26e-05	0.00039	CcSEcCtD
Bortezomib—Cough—Bupropion—obesity	5.25e-05	0.000389	CcSEcCtD
Bortezomib—Paraesthesia—Orlistat—obesity	5.22e-05	0.000387	CcSEcCtD
Bortezomib—Pancytopenia—Topiramate—obesity	5.22e-05	0.000387	CcSEcCtD
Bortezomib—Convulsion—Bupropion—obesity	5.21e-05	0.000386	CcSEcCtD
Bortezomib—Hypertension—Bupropion—obesity	5.19e-05	0.000385	CcSEcCtD
Bortezomib—Neutropenia—Topiramate—obesity	5.14e-05	0.000381	CcSEcCtD
Bortezomib—Musculoskeletal discomfort—Sibutramine—obesity	5.13e-05	0.00038	CcSEcCtD
Bortezomib—Dyspepsia—Orlistat—obesity	5.12e-05	0.000379	CcSEcCtD
Bortezomib—Myalgia—Bupropion—obesity	5.12e-05	0.000379	CcSEcCtD
Bortezomib—Arthralgia—Bupropion—obesity	5.12e-05	0.000379	CcSEcCtD
Bortezomib—Chest pain—Bupropion—obesity	5.12e-05	0.000379	CcSEcCtD
Bortezomib—Upper respiratory tract infection—Topiramate—obesity	5.11e-05	0.000379	CcSEcCtD
Bortezomib—Anxiety—Bupropion—obesity	5.1e-05	0.000378	CcSEcCtD
Bortezomib—Insomnia—Sibutramine—obesity	5.09e-05	0.000377	CcSEcCtD
Bortezomib—Unspecified disorder of skin and subcutaneous tissue—Bupropion—obesity	5.08e-05	0.000377	CcSEcCtD
Bortezomib—Pollakiuria—Topiramate—obesity	5.08e-05	0.000376	CcSEcCtD
Bortezomib—Erectile dysfunction—Topiramate—obesity	5.06e-05	0.000375	CcSEcCtD
Bortezomib—Discomfort—Bupropion—obesity	5.06e-05	0.000375	CcSEcCtD
Bortezomib—Decreased appetite—Orlistat—obesity	5.06e-05	0.000375	CcSEcCtD
Bortezomib—Paraesthesia—Sibutramine—obesity	5.05e-05	0.000375	CcSEcCtD
Bortezomib—Gastrointestinal disorder—Orlistat—obesity	5.02e-05	0.000372	CcSEcCtD
Bortezomib—Dyspnoea—Sibutramine—obesity	5.02e-05	0.000372	CcSEcCtD
Bortezomib—Photosensitivity reaction—Topiramate—obesity	5.02e-05	0.000372	CcSEcCtD
Bortezomib—Fatigue—Orlistat—obesity	5.01e-05	0.000372	CcSEcCtD
Bortezomib—Weight increased—Topiramate—obesity	5e-05	0.000371	CcSEcCtD
Bortezomib—Weight decreased—Topiramate—obesity	4.97e-05	0.000369	CcSEcCtD
Bortezomib—Pain—Orlistat—obesity	4.97e-05	0.000369	CcSEcCtD
Bortezomib—Hyperglycaemia—Topiramate—obesity	4.96e-05	0.000367	CcSEcCtD
Bortezomib—Dyspepsia—Sibutramine—obesity	4.96e-05	0.000367	CcSEcCtD
Bortezomib—Confusional state—Bupropion—obesity	4.95e-05	0.000367	CcSEcCtD
Bortezomib—Pneumonia—Topiramate—obesity	4.93e-05	0.000365	CcSEcCtD
Bortezomib—Oedema—Bupropion—obesity	4.91e-05	0.000364	CcSEcCtD
Bortezomib—Anaphylactic shock—Bupropion—obesity	4.91e-05	0.000364	CcSEcCtD
Bortezomib—Infestation—Topiramate—obesity	4.9e-05	0.000363	CcSEcCtD
Bortezomib—Infestation NOS—Topiramate—obesity	4.9e-05	0.000363	CcSEcCtD
Bortezomib—Decreased appetite—Sibutramine—obesity	4.89e-05	0.000363	CcSEcCtD
Bortezomib—Infection—Bupropion—obesity	4.88e-05	0.000361	CcSEcCtD
Bortezomib—Stevens-Johnson syndrome—Topiramate—obesity	4.86e-05	0.00036	CcSEcCtD
Bortezomib—Gastrointestinal disorder—Sibutramine—obesity	4.86e-05	0.00036	CcSEcCtD
Bortezomib—Shock—Bupropion—obesity	4.83e-05	0.000358	CcSEcCtD
Bortezomib—Renal failure—Topiramate—obesity	4.82e-05	0.000357	CcSEcCtD
Bortezomib—Pain—Sibutramine—obesity	4.81e-05	0.000357	CcSEcCtD
Bortezomib—Constipation—Sibutramine—obesity	4.81e-05	0.000357	CcSEcCtD
Bortezomib—Nervous system disorder—Bupropion—obesity	4.81e-05	0.000357	CcSEcCtD
Bortezomib—Neuropathy peripheral—Topiramate—obesity	4.81e-05	0.000356	CcSEcCtD
Bortezomib—Thrombocytopenia—Bupropion—obesity	4.81e-05	0.000356	CcSEcCtD
Bortezomib—Feeling abnormal—Orlistat—obesity	4.79e-05	0.000355	CcSEcCtD
Bortezomib—Tachycardia—Bupropion—obesity	4.79e-05	0.000355	CcSEcCtD
Bortezomib—Stomatitis—Topiramate—obesity	4.78e-05	0.000354	CcSEcCtD
Bortezomib—Skin disorder—Bupropion—obesity	4.77e-05	0.000353	CcSEcCtD
Bortezomib—Conjunctivitis—Topiramate—obesity	4.77e-05	0.000353	CcSEcCtD
Bortezomib—Urinary tract infection—Topiramate—obesity	4.77e-05	0.000353	CcSEcCtD
Bortezomib—Gastrointestinal pain—Orlistat—obesity	4.76e-05	0.000352	CcSEcCtD
Bortezomib—Hyperhidrosis—Bupropion—obesity	4.74e-05	0.000352	CcSEcCtD
Bortezomib—Anorexia—Bupropion—obesity	4.68e-05	0.000347	CcSEcCtD
Bortezomib—Haematuria—Topiramate—obesity	4.67e-05	0.000346	CcSEcCtD
Bortezomib—Feeling abnormal—Sibutramine—obesity	4.64e-05	0.000344	CcSEcCtD
Bortezomib—Epistaxis—Topiramate—obesity	4.62e-05	0.000343	CcSEcCtD
Bortezomib—Urticaria—Orlistat—obesity	4.62e-05	0.000342	CcSEcCtD
Bortezomib—Gastrointestinal pain—Sibutramine—obesity	4.6e-05	0.000341	CcSEcCtD
Bortezomib—Sinusitis—Topiramate—obesity	4.6e-05	0.000341	CcSEcCtD
Bortezomib—Body temperature increased—Orlistat—obesity	4.6e-05	0.000341	CcSEcCtD
Bortezomib—Abdominal pain—Orlistat—obesity	4.6e-05	0.000341	CcSEcCtD
Bortezomib—Hypotension—Bupropion—obesity	4.59e-05	0.00034	CcSEcCtD
Bortezomib—Bradycardia—Topiramate—obesity	4.48e-05	0.000332	CcSEcCtD
Bortezomib—Urticaria—Sibutramine—obesity	4.47e-05	0.000331	CcSEcCtD
Bortezomib—Musculoskeletal discomfort—Bupropion—obesity	4.47e-05	0.000331	CcSEcCtD
Bortezomib—Abdominal pain—Sibutramine—obesity	4.45e-05	0.00033	CcSEcCtD
Bortezomib—Body temperature increased—Sibutramine—obesity	4.45e-05	0.00033	CcSEcCtD
Bortezomib—Insomnia—Bupropion—obesity	4.44e-05	0.000329	CcSEcCtD
Bortezomib—Haemoglobin—Topiramate—obesity	4.42e-05	0.000328	CcSEcCtD
Bortezomib—Paraesthesia—Bupropion—obesity	4.41e-05	0.000326	CcSEcCtD
Bortezomib—Haemorrhage—Topiramate—obesity	4.4e-05	0.000326	CcSEcCtD
Bortezomib—Hepatitis—Topiramate—obesity	4.4e-05	0.000326	CcSEcCtD
Bortezomib—Hypoaesthesia—Topiramate—obesity	4.38e-05	0.000324	CcSEcCtD
Bortezomib—Hallucination—Topiramate—obesity	4.38e-05	0.000324	CcSEcCtD
Bortezomib—Dyspnoea—Bupropion—obesity	4.38e-05	0.000324	CcSEcCtD
Bortezomib—Urinary tract disorder—Topiramate—obesity	4.35e-05	0.000322	CcSEcCtD
Bortezomib—Oedema peripheral—Topiramate—obesity	4.34e-05	0.000321	CcSEcCtD
Bortezomib—Connective tissue disorder—Topiramate—obesity	4.32e-05	0.00032	CcSEcCtD
Bortezomib—Dyspepsia—Bupropion—obesity	4.32e-05	0.00032	CcSEcCtD
Bortezomib—Urethral disorder—Topiramate—obesity	4.31e-05	0.00032	CcSEcCtD
Bortezomib—Hypersensitivity—Orlistat—obesity	4.29e-05	0.000318	CcSEcCtD
Bortezomib—Decreased appetite—Bupropion—obesity	4.27e-05	0.000316	CcSEcCtD
Bortezomib—Visual impairment—Topiramate—obesity	4.24e-05	0.000314	CcSEcCtD
Bortezomib—Gastrointestinal disorder—Bupropion—obesity	4.24e-05	0.000314	CcSEcCtD
Bortezomib—Fatigue—Bupropion—obesity	4.23e-05	0.000313	CcSEcCtD
Bortezomib—Pain—Bupropion—obesity	4.2e-05	0.000311	CcSEcCtD
Bortezomib—Constipation—Bupropion—obesity	4.2e-05	0.000311	CcSEcCtD
Bortezomib—Asthenia—Orlistat—obesity	4.17e-05	0.000309	CcSEcCtD
Bortezomib—Erythema multiforme—Topiramate—obesity	4.16e-05	0.000308	CcSEcCtD
Bortezomib—Hypersensitivity—Sibutramine—obesity	4.15e-05	0.000307	CcSEcCtD
Bortezomib—Pruritus—Orlistat—obesity	4.12e-05	0.000305	CcSEcCtD
Bortezomib—Eye disorder—Topiramate—obesity	4.11e-05	0.000305	CcSEcCtD
Bortezomib—Tinnitus—Topiramate—obesity	4.1e-05	0.000304	CcSEcCtD
Bortezomib—Flushing—Topiramate—obesity	4.08e-05	0.000303	CcSEcCtD
Bortezomib—Cardiac disorder—Topiramate—obesity	4.08e-05	0.000303	CcSEcCtD
Bortezomib—Feeling abnormal—Bupropion—obesity	4.04e-05	0.0003	CcSEcCtD
Bortezomib—Asthenia—Sibutramine—obesity	4.04e-05	0.000299	CcSEcCtD
Bortezomib—Gastrointestinal pain—Bupropion—obesity	4.01e-05	0.000297	CcSEcCtD
Bortezomib—Angiopathy—Topiramate—obesity	3.99e-05	0.000296	CcSEcCtD
Bortezomib—Pruritus—Sibutramine—obesity	3.98e-05	0.000295	CcSEcCtD
Bortezomib—Diarrhoea—Orlistat—obesity	3.98e-05	0.000295	CcSEcCtD
Bortezomib—Immune system disorder—Topiramate—obesity	3.98e-05	0.000295	CcSEcCtD
Bortezomib—Mediastinal disorder—Topiramate—obesity	3.97e-05	0.000294	CcSEcCtD
Bortezomib—Chills—Topiramate—obesity	3.95e-05	0.000293	CcSEcCtD
Bortezomib—Urticaria—Bupropion—obesity	3.9e-05	0.000289	CcSEcCtD
Bortezomib—Abdominal pain—Bupropion—obesity	3.88e-05	0.000287	CcSEcCtD
Bortezomib—Body temperature increased—Bupropion—obesity	3.88e-05	0.000287	CcSEcCtD
Bortezomib—Mental disorder—Topiramate—obesity	3.86e-05	0.000286	CcSEcCtD
Bortezomib—Diarrhoea—Sibutramine—obesity	3.85e-05	0.000285	CcSEcCtD
Bortezomib—Dizziness—Orlistat—obesity	3.85e-05	0.000285	CcSEcCtD
Bortezomib—Erythema—Topiramate—obesity	3.83e-05	0.000284	CcSEcCtD
Bortezomib—Malnutrition—Topiramate—obesity	3.83e-05	0.000284	CcSEcCtD
Bortezomib—Flatulence—Topiramate—obesity	3.78e-05	0.00028	CcSEcCtD
Bortezomib—Dysgeusia—Topiramate—obesity	3.75e-05	0.000278	CcSEcCtD
Bortezomib—Dizziness—Sibutramine—obesity	3.72e-05	0.000276	CcSEcCtD
Bortezomib—Back pain—Topiramate—obesity	3.71e-05	0.000275	CcSEcCtD
Bortezomib—Vomiting—Orlistat—obesity	3.7e-05	0.000274	CcSEcCtD
Bortezomib—Muscle spasms—Topiramate—obesity	3.68e-05	0.000273	CcSEcCtD
Bortezomib—Rash—Orlistat—obesity	3.67e-05	0.000272	CcSEcCtD
Bortezomib—Dermatitis—Orlistat—obesity	3.66e-05	0.000271	CcSEcCtD
Bortezomib—Headache—Orlistat—obesity	3.64e-05	0.00027	CcSEcCtD
Bortezomib—Hypersensitivity—Bupropion—obesity	3.62e-05	0.000268	CcSEcCtD
Bortezomib—Vision blurred—Topiramate—obesity	3.61e-05	0.000268	CcSEcCtD
Bortezomib—Tremor—Topiramate—obesity	3.59e-05	0.000266	CcSEcCtD
Bortezomib—Vomiting—Sibutramine—obesity	3.58e-05	0.000265	CcSEcCtD
Bortezomib—Ill-defined disorder—Topiramate—obesity	3.55e-05	0.000263	CcSEcCtD
Bortezomib—Rash—Sibutramine—obesity	3.55e-05	0.000263	CcSEcCtD
Bortezomib—Dermatitis—Sibutramine—obesity	3.55e-05	0.000263	CcSEcCtD
Bortezomib—Anaemia—Topiramate—obesity	3.54e-05	0.000262	CcSEcCtD
Bortezomib—Headache—Sibutramine—obesity	3.53e-05	0.000261	CcSEcCtD
Bortezomib—Asthenia—Bupropion—obesity	3.52e-05	0.000261	CcSEcCtD
Bortezomib—Agitation—Topiramate—obesity	3.52e-05	0.000261	CcSEcCtD
Bortezomib—Pruritus—Bupropion—obesity	3.47e-05	0.000257	CcSEcCtD
Bortezomib—Nausea—Orlistat—obesity	3.46e-05	0.000256	CcSEcCtD
Bortezomib—Malaise—Topiramate—obesity	3.45e-05	0.000256	CcSEcCtD
Bortezomib—Vertigo—Topiramate—obesity	3.44e-05	0.000255	CcSEcCtD
Bortezomib—Syncope—Topiramate—obesity	3.44e-05	0.000255	CcSEcCtD
Bortezomib—Leukopenia—Topiramate—obesity	3.43e-05	0.000254	CcSEcCtD
Bortezomib—Palpitations—Topiramate—obesity	3.39e-05	0.000251	CcSEcCtD
Bortezomib—Loss of consciousness—Topiramate—obesity	3.37e-05	0.000249	CcSEcCtD
Bortezomib—Diarrhoea—Bupropion—obesity	3.36e-05	0.000249	CcSEcCtD
Bortezomib—Nausea—Sibutramine—obesity	3.34e-05	0.000248	CcSEcCtD
Bortezomib—Cough—Topiramate—obesity	3.34e-05	0.000248	CcSEcCtD
Bortezomib—Convulsion—Topiramate—obesity	3.32e-05	0.000246	CcSEcCtD
Bortezomib—Hypertension—Topiramate—obesity	3.31e-05	0.000245	CcSEcCtD
Bortezomib—Myalgia—Topiramate—obesity	3.26e-05	0.000242	CcSEcCtD
Bortezomib—Arthralgia—Topiramate—obesity	3.26e-05	0.000242	CcSEcCtD
Bortezomib—Chest pain—Topiramate—obesity	3.26e-05	0.000242	CcSEcCtD
Bortezomib—Anxiety—Topiramate—obesity	3.25e-05	0.000241	CcSEcCtD
Bortezomib—Dizziness—Bupropion—obesity	3.25e-05	0.00024	CcSEcCtD
Bortezomib—Unspecified disorder of skin and subcutaneous tissue—Topiramate—obesity	3.24e-05	0.00024	CcSEcCtD
Bortezomib—Discomfort—Topiramate—obesity	3.22e-05	0.000239	CcSEcCtD
Bortezomib—Confusional state—Topiramate—obesity	3.15e-05	0.000234	CcSEcCtD
Bortezomib—Oedema—Topiramate—obesity	3.13e-05	0.000232	CcSEcCtD
Bortezomib—Vomiting—Bupropion—obesity	3.12e-05	0.000231	CcSEcCtD
Bortezomib—Infection—Topiramate—obesity	3.11e-05	0.00023	CcSEcCtD
Bortezomib—Rash—Bupropion—obesity	3.09e-05	0.000229	CcSEcCtD
Bortezomib—Dermatitis—Bupropion—obesity	3.09e-05	0.000229	CcSEcCtD
Bortezomib—Shock—Topiramate—obesity	3.08e-05	0.000228	CcSEcCtD
Bortezomib—Headache—Bupropion—obesity	3.07e-05	0.000228	CcSEcCtD
Bortezomib—Nervous system disorder—Topiramate—obesity	3.07e-05	0.000227	CcSEcCtD
Bortezomib—Thrombocytopenia—Topiramate—obesity	3.06e-05	0.000227	CcSEcCtD
Bortezomib—Tachycardia—Topiramate—obesity	3.05e-05	0.000226	CcSEcCtD
Bortezomib—Skin disorder—Topiramate—obesity	3.04e-05	0.000225	CcSEcCtD
Bortezomib—Hyperhidrosis—Topiramate—obesity	3.02e-05	0.000224	CcSEcCtD
Bortezomib—Anorexia—Topiramate—obesity	2.98e-05	0.000221	CcSEcCtD
Bortezomib—Hypotension—Topiramate—obesity	2.92e-05	0.000216	CcSEcCtD
Bortezomib—Nausea—Bupropion—obesity	2.92e-05	0.000216	CcSEcCtD
Bortezomib—Musculoskeletal discomfort—Topiramate—obesity	2.85e-05	0.000211	CcSEcCtD
Bortezomib—Insomnia—Topiramate—obesity	2.83e-05	0.00021	CcSEcCtD
Bortezomib—Paraesthesia—Topiramate—obesity	2.81e-05	0.000208	CcSEcCtD
Bortezomib—Dyspnoea—Topiramate—obesity	2.79e-05	0.000207	CcSEcCtD
Bortezomib—Dyspepsia—Topiramate—obesity	2.75e-05	0.000204	CcSEcCtD
Bortezomib—Decreased appetite—Topiramate—obesity	2.72e-05	0.000201	CcSEcCtD
Bortezomib—Gastrointestinal disorder—Topiramate—obesity	2.7e-05	0.0002	CcSEcCtD
Bortezomib—Fatigue—Topiramate—obesity	2.7e-05	0.0002	CcSEcCtD
Bortezomib—Pain—Topiramate—obesity	2.67e-05	0.000198	CcSEcCtD
Bortezomib—Constipation—Topiramate—obesity	2.67e-05	0.000198	CcSEcCtD
Bortezomib—Feeling abnormal—Topiramate—obesity	2.58e-05	0.000191	CcSEcCtD
Bortezomib—Gastrointestinal pain—Topiramate—obesity	2.56e-05	0.000189	CcSEcCtD
Bortezomib—Urticaria—Topiramate—obesity	2.48e-05	0.000184	CcSEcCtD
Bortezomib—Abdominal pain—Topiramate—obesity	2.47e-05	0.000183	CcSEcCtD
Bortezomib—Body temperature increased—Topiramate—obesity	2.47e-05	0.000183	CcSEcCtD
Bortezomib—Hypersensitivity—Topiramate—obesity	2.3e-05	0.000171	CcSEcCtD
Bortezomib—Asthenia—Topiramate—obesity	2.24e-05	0.000166	CcSEcCtD
Bortezomib—Pruritus—Topiramate—obesity	2.21e-05	0.000164	CcSEcCtD
Bortezomib—Diarrhoea—Topiramate—obesity	2.14e-05	0.000158	CcSEcCtD
Bortezomib—Dizziness—Topiramate—obesity	2.07e-05	0.000153	CcSEcCtD
Bortezomib—Vomiting—Topiramate—obesity	1.99e-05	0.000147	CcSEcCtD
Bortezomib—Rash—Topiramate—obesity	1.97e-05	0.000146	CcSEcCtD
Bortezomib—Dermatitis—Topiramate—obesity	1.97e-05	0.000146	CcSEcCtD
Bortezomib—Headache—Topiramate—obesity	1.96e-05	0.000145	CcSEcCtD
Bortezomib—Nausea—Topiramate—obesity	1.86e-05	0.000138	CcSEcCtD
Bortezomib—CYP2C9—Metabolism—NCOA1—obesity	1.4e-06	1.26e-05	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—GLP1R—obesity	1.39e-06	1.26e-05	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—SULT2A1—obesity	1.39e-06	1.26e-05	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—STK11—obesity	1.39e-06	1.26e-05	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—CYP19A1—obesity	1.39e-06	1.26e-05	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism—MTHFR—obesity	1.39e-06	1.25e-05	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—obesity	1.39e-06	1.25e-05	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—GNB3—obesity	1.39e-06	1.25e-05	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—PPARGC1A—obesity	1.39e-06	1.25e-05	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—HMOX1—obesity	1.38e-06	1.25e-05	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—GPX1—obesity	1.38e-06	1.25e-05	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—CYP19A1—obesity	1.38e-06	1.25e-05	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—STK11—obesity	1.38e-06	1.25e-05	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—FASN—obesity	1.37e-06	1.24e-05	CbGpPWpGaD
Bortezomib—PTGS1—Metabolism—PIK3R1—obesity	1.37e-06	1.24e-05	CbGpPWpGaD
Bortezomib—PTGS1—Metabolism—NOS3—obesity	1.37e-06	1.24e-05	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—DPYD—obesity	1.37e-06	1.24e-05	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—BCHE—obesity	1.37e-06	1.24e-05	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism—PPARA—obesity	1.36e-06	1.23e-05	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—GNAS—obesity	1.35e-06	1.22e-05	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—CD36—obesity	1.34e-06	1.21e-05	CbGpPWpGaD
Bortezomib—PSMA1—Signaling Pathways—AKT1—obesity	1.33e-06	1.2e-05	CbGpPWpGaD
Bortezomib—PSMD1—Signaling Pathways—AKT1—obesity	1.33e-06	1.2e-05	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—CYP2E1—obesity	1.32e-06	1.19e-05	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—APOB—obesity	1.32e-06	1.19e-05	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—PRKAR2B—obesity	1.32e-06	1.19e-05	CbGpPWpGaD
Bortezomib—PSMD2—Signaling Pathways—AKT1—obesity	1.32e-06	1.19e-05	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism—AGT—obesity	1.32e-06	1.19e-05	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—DCN—obesity	1.31e-06	1.18e-05	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—NQO1—obesity	1.31e-06	1.18e-05	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—COMT—obesity	1.29e-06	1.17e-05	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism—APOE—obesity	1.29e-06	1.17e-05	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—COMT—obesity	1.28e-06	1.16e-05	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism—CAV1—obesity	1.28e-06	1.16e-05	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—obesity	1.28e-06	1.16e-05	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism—APOA1—obesity	1.28e-06	1.15e-05	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—CPT1A—obesity	1.28e-06	1.15e-05	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—PPARGC1A—obesity	1.27e-06	1.15e-05	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—GNB3—obesity	1.27e-06	1.15e-05	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—MTHFR—obesity	1.27e-06	1.15e-05	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—HMOX1—obesity	1.27e-06	1.15e-05	CbGpPWpGaD
Bortezomib—PTGS1—Metabolism—PIK3CB—obesity	1.27e-06	1.15e-05	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—obesity	1.27e-06	1.15e-05	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—PPARGC1A—obesity	1.26e-06	1.14e-05	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—GNB3—obesity	1.26e-06	1.14e-05	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—LPL—obesity	1.26e-06	1.14e-05	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—HMOX1—obesity	1.26e-06	1.14e-05	CbGpPWpGaD
Bortezomib—PTGS1—Metabolism—PTGS2—obesity	1.26e-06	1.14e-05	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—GCG—obesity	1.25e-06	1.13e-05	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—SLC2A4—obesity	1.25e-06	1.13e-05	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—NAMPT—obesity	1.25e-06	1.13e-05	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—PPARA—obesity	1.25e-06	1.13e-05	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—LIPC—obesity	1.24e-06	1.12e-05	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—GCK—obesity	1.24e-06	1.12e-05	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—GNAS—obesity	1.24e-06	1.12e-05	CbGpPWpGaD
Bortezomib—PSMB2—Signaling Pathways—PIK3CA—obesity	1.24e-06	1.12e-05	CbGpPWpGaD
Bortezomib—PSMB5—Signaling Pathways—PIK3CA—obesity	1.24e-06	1.12e-05	CbGpPWpGaD
Bortezomib—PSMB1—Signaling Pathways—PIK3CA—obesity	1.24e-06	1.12e-05	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—CYCS—obesity	1.24e-06	1.12e-05	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—APOC3—obesity	1.24e-06	1.12e-05	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—GPX1—obesity	1.23e-06	1.11e-05	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—GNAS—obesity	1.23e-06	1.11e-05	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—obesity	1.22e-06	1.11e-05	CbGpPWpGaD
Bortezomib—PSMB8—Signaling Pathways—PIK3CA—obesity	1.22e-06	1.1e-05	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—APOB—obesity	1.21e-06	1.1e-05	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—GOT1—obesity	1.21e-06	1.1e-05	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—GGT1—obesity	1.21e-06	1.1e-05	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—AGT—obesity	1.21e-06	1.09e-05	CbGpPWpGaD
Bortezomib—PSMB2—Metabolism—AKT1—obesity	1.21e-06	1.09e-05	CbGpPWpGaD
Bortezomib—PSMB1—Metabolism—AKT1—obesity	1.21e-06	1.09e-05	CbGpPWpGaD
Bortezomib—PSMB5—Metabolism—AKT1—obesity	1.21e-06	1.09e-05	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—APOB—obesity	1.2e-06	1.09e-05	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—CETP—obesity	1.2e-06	1.08e-05	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—CD36—obesity	1.2e-06	1.08e-05	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—NCOA1—obesity	1.19e-06	1.08e-05	CbGpPWpGaD
Bortezomib—PSMB8—Metabolism—AKT1—obesity	1.19e-06	1.08e-05	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—SDC1—obesity	1.19e-06	1.07e-05	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—APOE—obesity	1.18e-06	1.07e-05	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—STK11—obesity	1.18e-06	1.06e-05	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—CYP19A1—obesity	1.18e-06	1.06e-05	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—CAV1—obesity	1.17e-06	1.06e-05	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—APOA1—obesity	1.17e-06	1.06e-05	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—AKR1C3—obesity	1.17e-06	1.05e-05	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism—PIK3CG—obesity	1.17e-06	1.05e-05	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—LPL—obesity	1.16e-06	1.05e-05	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—LPL—obesity	1.15e-06	1.04e-05	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—SCARB1—obesity	1.15e-06	1.04e-05	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—MTHFR—obesity	1.14e-06	1.03e-05	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—GPX1—obesity	1.13e-06	1.02e-05	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism—PPARG—obesity	1.13e-06	1.02e-05	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—GPX1—obesity	1.12e-06	1.01e-05	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—obesity	1.12e-06	1.01e-05	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—SREBF1—obesity	1.11e-06	1.01e-05	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—PPARA—obesity	1.11e-06	1.01e-05	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism—POMC—obesity	1.11e-06	1e-05	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism—INS—obesity	1.1e-06	9.98e-06	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—CD36—obesity	1.1e-06	9.96e-06	CbGpPWpGaD
Bortezomib—PSMB5—Signaling Pathways—IL6—obesity	1.09e-06	9.9e-06	CbGpPWpGaD
Bortezomib—PSMB1—Signaling Pathways—IL6—obesity	1.09e-06	9.9e-06	CbGpPWpGaD
Bortezomib—PSMB2—Signaling Pathways—IL6—obesity	1.09e-06	9.9e-06	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—COMT—obesity	1.09e-06	9.89e-06	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—CD36—obesity	1.09e-06	9.88e-06	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—GOT2—obesity	1.08e-06	9.8e-06	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—GNB3—obesity	1.08e-06	9.76e-06	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—PPARGC1A—obesity	1.08e-06	9.76e-06	CbGpPWpGaD
Bortezomib—PSMB8—Signaling Pathways—IL6—obesity	1.08e-06	9.76e-06	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—AGT—obesity	1.08e-06	9.75e-06	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—HMOX1—obesity	1.07e-06	9.71e-06	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—PIK3CG—obesity	1.07e-06	9.66e-06	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—FASN—obesity	1.06e-06	9.59e-06	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—APOE—obesity	1.06e-06	9.56e-06	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—BCHE—obesity	1.06e-06	9.55e-06	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—GNAS—obesity	1.05e-06	9.5e-06	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—CAV1—obesity	1.05e-06	9.47e-06	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—APOA1—obesity	1.05e-06	9.45e-06	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—MTHFR—obesity	1.04e-06	9.44e-06	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—MTHFR—obesity	1.04e-06	9.36e-06	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—PPARG—obesity	1.03e-06	9.32e-06	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—APOB—obesity	1.03e-06	9.3e-06	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism—PIK3CD—obesity	1.02e-06	9.26e-06	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—PPARA—obesity	1.02e-06	9.26e-06	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—CYP2E1—obesity	1.02e-06	9.22e-06	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—POMC—obesity	1.02e-06	9.2e-06	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—PPARA—obesity	1.02e-06	9.18e-06	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—INS—obesity	1.01e-06	9.15e-06	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism—ALB—obesity	1.01e-06	9.15e-06	CbGpPWpGaD
Bortezomib—PSMB1—Signaling Pathways—AKT1—obesity	1.01e-06	9.13e-06	CbGpPWpGaD
Bortezomib—PSMB2—Signaling Pathways—AKT1—obesity	1.01e-06	9.13e-06	CbGpPWpGaD
Bortezomib—PSMB5—Signaling Pathways—AKT1—obesity	1.01e-06	9.13e-06	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—NQO1—obesity	1.01e-06	9.11e-06	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—obesity	1e-06	9.05e-06	CbGpPWpGaD
Bortezomib—PSMB8—Signaling Pathways—AKT1—obesity	9.96e-07	9e-06	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—AGT—obesity	9.92e-07	8.97e-06	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—AGT—obesity	9.84e-07	8.89e-06	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—LPL—obesity	9.83e-07	8.88e-06	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—APOE—obesity	9.72e-07	8.79e-06	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism—PIK3R1—obesity	9.68e-07	8.75e-06	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism—NOS3—obesity	9.68e-07	8.75e-06	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—SLC2A4—obesity	9.66e-07	8.74e-06	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—GCG—obesity	9.66e-07	8.74e-06	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—APOE—obesity	9.64e-07	8.71e-06	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—CAV1—obesity	9.63e-07	8.71e-06	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—APOA1—obesity	9.61e-07	8.69e-06	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—GPX1—obesity	9.59e-07	8.67e-06	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—CAV1—obesity	9.55e-07	8.63e-06	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—PIK3CG—obesity	9.54e-07	8.62e-06	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—CYCS—obesity	9.54e-07	8.62e-06	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—APOA1—obesity	9.53e-07	8.61e-06	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—PIK3CD—obesity	9.4e-07	8.49e-06	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—GGT1—obesity	9.36e-07	8.46e-06	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—GOT1—obesity	9.36e-07	8.46e-06	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—CD36—obesity	9.34e-07	8.44e-06	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—ALB—obesity	9.28e-07	8.38e-06	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—NCOA1—obesity	9.22e-07	8.33e-06	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—PPARG—obesity	9.21e-07	8.32e-06	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—obesity	9.12e-07	8.25e-06	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—STK11—obesity	9.09e-07	8.21e-06	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—CYP19A1—obesity	9.09e-07	8.21e-06	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—POMC—obesity	9.08e-07	8.21e-06	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—INS—obesity	9.03e-07	8.16e-06	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism—PIK3CB—obesity	8.93e-07	8.08e-06	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—PIK3R1—obesity	8.87e-07	8.02e-06	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—NOS3—obesity	8.87e-07	8.02e-06	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism—PTGS2—obesity	8.85e-07	8e-06	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—MTHFR—obesity	8.85e-07	8e-06	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—PIK3CG—obesity	8.78e-07	7.93e-06	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—PIK3CG—obesity	8.7e-07	7.86e-06	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—PPARA—obesity	8.68e-07	7.85e-06	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—PPARG—obesity	8.47e-07	7.66e-06	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—COMT—obesity	8.45e-07	7.64e-06	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—AGT—obesity	8.41e-07	7.6e-06	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—PPARG—obesity	8.4e-07	7.59e-06	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—PIK3CD—obesity	8.39e-07	7.58e-06	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—POMC—obesity	8.35e-07	7.55e-06	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—PPARGC1A—obesity	8.33e-07	7.53e-06	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—GNB3—obesity	8.33e-07	7.53e-06	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—INS—obesity	8.31e-07	7.51e-06	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—HMOX1—obesity	8.29e-07	7.5e-06	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—POMC—obesity	8.28e-07	7.48e-06	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—ALB—obesity	8.28e-07	7.48e-06	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—APOE—obesity	8.24e-07	7.45e-06	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—INS—obesity	8.23e-07	7.44e-06	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—PIK3CB—obesity	8.19e-07	7.4e-06	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—CAV1—obesity	8.16e-07	7.38e-06	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—APOA1—obesity	8.14e-07	7.36e-06	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—PTGS2—obesity	8.12e-07	7.34e-06	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—GNAS—obesity	8.11e-07	7.33e-06	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—APOB—obesity	7.94e-07	7.18e-06	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—PIK3R1—obesity	7.92e-07	7.16e-06	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—NOS3—obesity	7.92e-07	7.16e-06	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—obesity	7.8e-07	7.05e-06	CbGpPWpGaD
Bortezomib—PTGS1—Metabolism—PIK3CA—obesity	7.73e-07	6.99e-06	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—PIK3CD—obesity	7.71e-07	6.97e-06	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—PIK3CD—obesity	7.65e-07	6.91e-06	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—ALB—obesity	7.62e-07	6.88e-06	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—LPL—obesity	7.58e-07	6.86e-06	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—ALB—obesity	7.55e-07	6.82e-06	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—PIK3CG—obesity	7.43e-07	6.72e-06	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—GPX1—obesity	7.4e-07	6.69e-06	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—PIK3CB—obesity	7.31e-07	6.61e-06	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—PIK3R1—obesity	7.28e-07	6.58e-06	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—NOS3—obesity	7.28e-07	6.58e-06	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—PTGS2—obesity	7.24e-07	6.55e-06	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—PIK3R1—obesity	7.22e-07	6.53e-06	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—NOS3—obesity	7.22e-07	6.53e-06	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—CD36—obesity	7.21e-07	6.51e-06	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—PPARG—obesity	7.17e-07	6.49e-06	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—POMC—obesity	7.08e-07	6.4e-06	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—INS—obesity	7.04e-07	6.36e-06	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—MTHFR—obesity	6.83e-07	6.17e-06	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—PIK3CB—obesity	6.72e-07	6.08e-06	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—PPARA—obesity	6.7e-07	6.06e-06	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—PIK3CB—obesity	6.67e-07	6.03e-06	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—PTGS2—obesity	6.66e-07	6.02e-06	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—PTGS2—obesity	6.6e-07	5.97e-06	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—PIK3CD—obesity	6.54e-07	5.91e-06	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—AGT—obesity	6.49e-07	5.86e-06	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—ALB—obesity	6.45e-07	5.83e-06	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—APOE—obesity	6.36e-07	5.75e-06	CbGpPWpGaD
Bortezomib—PTGS1—Metabolism—AKT1—obesity	6.31e-07	5.71e-06	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—CAV1—obesity	6.3e-07	5.69e-06	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—APOA1—obesity	6.28e-07	5.68e-06	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—PIK3R1—obesity	6.17e-07	5.58e-06	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—NOS3—obesity	6.17e-07	5.58e-06	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—PIK3CG—obesity	5.74e-07	5.19e-06	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—PIK3CB—obesity	5.7e-07	5.15e-06	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—PTGS2—obesity	5.64e-07	5.1e-06	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—PPARG—obesity	5.54e-07	5.01e-06	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—POMC—obesity	5.46e-07	4.94e-06	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism—PIK3CA—obesity	5.45e-07	4.92e-06	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—INS—obesity	5.43e-07	4.91e-06	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—PIK3CD—obesity	5.04e-07	4.56e-06	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—PIK3CA—obesity	4.99e-07	4.51e-06	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—ALB—obesity	4.98e-07	4.5e-06	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—PIK3R1—obesity	4.76e-07	4.3e-06	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—NOS3—obesity	4.76e-07	4.3e-06	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—PIK3CA—obesity	4.46e-07	4.03e-06	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism—AKT1—obesity	4.45e-07	4.02e-06	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—PIK3CB—obesity	4.4e-07	3.97e-06	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—PTGS2—obesity	4.36e-07	3.94e-06	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—PIK3CA—obesity	4.1e-07	3.71e-06	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—AKT1—obesity	4.08e-07	3.69e-06	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—PIK3CA—obesity	4.06e-07	3.67e-06	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—AKT1—obesity	3.64e-07	3.29e-06	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—PIK3CA—obesity	3.47e-07	3.14e-06	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—AKT1—obesity	3.35e-07	3.03e-06	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—AKT1—obesity	3.32e-07	3e-06	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—AKT1—obesity	2.84e-07	2.56e-06	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—PIK3CA—obesity	2.68e-07	2.42e-06	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—AKT1—obesity	2.19e-07	1.98e-06	CbGpPWpGaD
